Orange, CA, United States of America

Miao Zhang

This inventor holds 1 USPTO granted patent. Top assignees: Chapman University, Northeastern University, The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miao Zhang. Retrieved from https://idiyas.com/inventor/miao-zhang-0a6m0fx0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miao Zhang: Innovator in Pharmaceutical Modulation

Introduction

Miao Zhang is a notable inventor based in Orange, California, recognized for his contributions to the field of pharmaceutical science. He holds a patent that focuses on positive allosteric modulators, which are crucial in enhancing the efficacy of certain drugs.

Latest Patents

Zhang's most recent patent is titled "SK channel positive allosteric modulators." This patent describes a compound according to a specific formula, which includes various chemical components that can be utilized in pharmaceutical applications. The formula outlines the structural components, including options for substituents that can enhance the compound's effectiveness.

Career Highlights

Throughout his career, Miao Zhang has worked with prestigious institutions such as Chapman University and the University of Texas System. His work in these organizations has contributed significantly to advancements in pharmaceutical research and development.

Collaborations

Zhang has collaborated with notable colleagues, including Keykavous Parang and Naglaa Ibrahim. These partnerships have fostered innovative research and development in the field of drug modulation.

Conclusion

Miao Zhang's contributions to pharmaceutical science through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…